Centre for Reviews and Dissemination, University of York, York YO10 5DD, UK.
Eur Spine J. 2013 Feb;22(2):296-304. doi: 10.1007/s00586-012-2469-7. Epub 2012 Aug 19.
To evaluate the available evidence for the clinical effectiveness of the EOS(®) 2D/3D X-ray imaging system for the evaluation and monitoring of scoliosis and other relevant orthopaedic conditions.
A systematic review of studies of EOS(®), compared with standard X-ray film, computed radiography or digital radiography, of patients with orthopaedic conditions was undertaken. Ten electronic databases were searched. The quality of the included studies was assessed and a narrative synthesis undertaken.
Three small, limited quality studies, primarily of children with scoliosis, were identified. No patient health outcomes were reported. Spinal image quality was comparable or better overall with EOS(®). Radiation dose was considerably lower with EOS(®) than X-ray film or computed radiography; the mean entrance surface dose was over five times lower with EOS(®) for the posteroanterior spine radiograph and over six times lower for the lateral spine radiograph.
The available clinical evidence for EOS(®) is limited to establishing its basic technical ability. The technical advancements associated with EOS(®) (the ability to generate a full body scan and to construct a three-dimensional model from synchronously acquired lateral and posteroanterior images) have not been evaluated in terms of their ability to improve patient outcomes. Whilst radiation dose is a concern for orthopaedic patients who require repeated imaging, it is difficult to quantify the reductions in radiation dose seen with EOS(®) in terms of patient health benefits. Clinical studies that investigate the impact of EOS(®) on patient management are required.
评估 EOS(®)2D/3D X 射线成像系统在评估和监测脊柱侧弯和其他相关骨科疾病方面的临床效果的现有证据。
对 EOS(®)与标准 X 射线胶片、计算机射线照相术或数字射线照相术对比的骨科疾病患者的研究进行了系统评价。搜索了 10 个电子数据库。评估了纳入研究的质量,并进行了叙述性综合。
确定了三项小型、质量有限的研究,主要针对脊柱侧弯的儿童。没有报告患者的健康结果。EOS(®)的脊柱图像质量总体上相当或更好。EOS(®)的辐射剂量明显低于 X 射线胶片或计算机射线照相术;EOS(®)的后前位脊柱射线照相术的入口表面剂量平均值低 5 倍以上,侧位脊柱射线照相术低 6 倍以上。
EOS(®)的现有临床证据仅限于确定其基本技术能力。与 EOS(®)相关的技术进步(从同步采集的侧位和后前位图像生成全身扫描并构建三维模型的能力)尚未评估其改善患者结局的能力。虽然对于需要重复成像的骨科患者来说,辐射剂量是一个问题,但很难从患者健康获益的角度量化 EOS(®)所见的辐射剂量减少。需要进行研究 EOS(®)对患者管理影响的临床研究。